Document is current
Any future updates will be listed below
-
Authors
Wu, Yu-Fu https://orcid.org/0000-0003-4452-1724
Chen, Jun-An https://orcid.org/0000-0001-9870-3203
Jong, Yuh-Jyh https://orcid.org/0000-0002-1735-1101
-
Funding
Funding for this research was provided by:
National Science and Technology Council (113-2326-B-001-001)
National Science and Technology Council (112-2321-B-037-006)
National Science and Technology Council (113-2321-B-037-008)
National Health Research Institutes (NHRI-EX113-11330NI)
Academia Sinica (AS-GCP-113-L02)
Academia Sinica (AS-BRPT-113-01)
- License Information
-
More Information
Article History
Received: 29 August 2024
Accepted: 21 January 2025
First Online: 21 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: Y.-J.J. received an honorarium for consulting, serving on a scientific advisory board, speaking, or other activities for Biogen, Roche, Novartis, and Pfizer; research grants for SMA natural history in Taiwan from Biogen; and clinical trial funding from Biogen, Roche, Novartis, PTC, Pfizer, and Sarepta. He is also the founder and executive director of the non-profit organization Taiwan SMA Families. Other authors declare no competing interests.
